다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Vanda Pharmaceuticals Inc (VNDA)
Vanda Pharmaceuticals Inc (VNDA) 뉴스

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2009/05/14	21:30	Marketwired	Market Pulse Breaking News Alert for Thursday, May 14, 2009: MNGA -- MagneGas Corp. Continues International Expansion With Israe	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/14	05:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/14	05:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/14	05:05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/14	05:01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/13	04:36	Dow Jones News	Schering-Plough Gears Up For Possible Antipsychotic Launch	NASDAQ:VNDA	Vanda Pharmaceuticals Inc.
2009/05/12	04:36	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/08	22:41	PR Newswire (US)	Markets Respond to Banks' Stress Tests; Trading Spurred by News Releases and Updates - Stock Alerts on: CPKI, HOTT, VNDA, BJ, CT	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/08	07:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/08	07:29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/08	07:27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/08	07:25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/08	03:53	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/08	03:52	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/07	22:00	PR Newswire (US)	Vanda Pharmaceuticals Announces Withdrawal of Director Nominees and Proposal to Liquidate Submitted by Tang Capital	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/07	19:04	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/07	19:01	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/07	19:01	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/07	11:23	Business Wire	Titan Announces FDA Approval of Fanapt™ (Iloperidone) For the Treatment of Schizophrenia	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/05/07	07:37	PR Newswire (US)	FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/04/30	01:28	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/04/29	20:00	PR Newswire (US)	Vanda Pharmaceuticals Reports First Quarter 2009 Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/04/29	19:01	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/04/07	19:02	Edgar (US Regulatory)	Proxy Statement - Contested Solicitations (preliminary) (PREC14A)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/03/14	05:30	Edgar (US Regulatory)	Annual Report (10-K)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/03/11	05:00	PR Newswire (US)	New Insights into the Mechanism of Action of Antipsychotic Drugs	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/03/06	00:31	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/02/24	07:21	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/02/24	07:19	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2009/02/24	07:17	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 다음 >>

Financial Select Sector

US Dollar vs Sterling

American Express

JP Morgan Chase

Deutsche Telekom (QX)

US Dollar vs Yen

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관